What does Pharmacie WAGMANS-CREMA do?

Pharmacie WAGMANS-CREMA is a pharmacy in Dalhem. Private Limited, started on 17 February 2009, 1 establishment.

What is the address of Pharmacie WAGMANS-CREMA?

The registered office of Pharmacie WAGMANS-CREMA is located at Rue des Fusillés(BER) 5, 4607 Dalhem.

Is Pharmacie WAGMANS-CREMA still active?

Yes. According to the CBE (31 October 2026) Pharmacie WAGMANS-CREMA is active, legal situation “Normale toestand”, started on 17 February 2009.

Is Pharmacie WAGMANS-CREMA registered on Peppol?

Yes, Pharmacie WAGMANS-CREMA is registered on the Peppol network with ID 0208:0809878140.

What is the enterprise number of Pharmacie WAGMANS-CREMA?

The enterprise number of Pharmacie WAGMANS-CREMA is BE0809878140.

When was Pharmacie WAGMANS-CREMA founded?

Pharmacie WAGMANS-CREMA was founded on 17 February 2009.

Who are the directors of Pharmacie WAGMANS-CREMA?

According to the 2024 annual accounts, the directors of Pharmacie WAGMANS-CREMA are: Daniella CREMA.

Is Pharmacie WAGMANS-CREMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 February 2009; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Pharmacie WAGMANS-CREMA make in 2024?

Pharmacie WAGMANS-CREMA posted a profit after taxes of € 15,265 in financial year 2024.

What is the revenue of Pharmacie WAGMANS-CREMA?

As a small company, Pharmacie WAGMANS-CREMA is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 67,891.

Pharmacie WAGMANS-CREMA (Private Limited) - Dalhem

Dossier Pharmacie WAGMANS-CREMA, printed on 31 October 2026 from databakkes.be/en/0809878140/pharmacie-wagmans-crema. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 57 % of short-term debt in 2024; threshold 65 %.

Financials

Financial year 2024

Pharmacie WAGMANS-CREMA from Dalhem, company number BE0809878140, closed financial year 2024 with a result of € 15,265 after tax. For that financial year Pharmacie WAGMANS-CREMA recorded a gross margin of € 67,891 and equity of € 56,108. Compared with financial year 2023, the result moved from € -474 to € 15,265. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2025.

What it is worth Healthy

€ 56,108

▼ 10% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 15,265

▲ still € 474 loss in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 30,614

▲ € 29,202 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 21,570 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 30,986

▲ 6% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,900

▲ 198% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 6,372

▼ 53% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 80,217

▼ 6% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,704

▲ 13% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 1,191 Gross margin 2021: € 1,191 First fiscal year in the series	€ 37,805 Gross margin 2022: € 37,805 ▲ € 36,615 vs 2021 (€ 1,191) Favourable step	€ 51,767 Gross margin 2023: € 51,767 ▲ 37% vs 2022 (€ 37,805) Favourable step	€ 67,891 Gross margin 2024: € 67,891 ▲ 31% vs 2023 (€ 51,767) Favourable step	▲ 31%
Profit after taxes	€ -42,761 Profit after taxes 2021: € -42,761 First fiscal year in the series	€ -11,394 Profit after taxes 2022: € -11,394 ▲ € 31,366 vs 2021 (€ -42,761) Favourable step	€ -474 Profit after taxes 2023: € -474 ▲ € 10,921 vs 2022 (€ -11,394) Favourable step	€ 15,265 Profit after taxes 2024: € 15,265 ▲ € 15,739 vs 2023 (€ -474) Favourable step	▲ € 15,739
Equity	€ 95,472 Equity 2021: € 95,472 First fiscal year in the series	€ 73,077 Equity 2022: € 73,077 ▼ 23% vs 2021 (€ 95,472) Unfavourable step	€ 62,413 Equity 2023: € 62,413 ▼ 15% vs 2022 (€ 73,077) Unfavourable step	€ 56,108 Equity 2024: € 56,108 ▼ 10% vs 2023 (€ 62,413) Unfavourable step	▼ 10%
Total debts	€ 143,118 Total debts 2021: € 143,118 First fiscal year in the series	€ 130,656 Total debts 2022: € 130,656 ▼ 9% vs 2021 (€ 143,118) Favourable step	€ 116,699 Total debts 2023: € 116,699 ▼ 11% vs 2022 (€ 130,656) Favourable step	€ 121,738 Total debts 2024: € 121,738 ▲ 4% vs 2023 (€ 116,699) Unfavourable step	▲ 4%
Cash	€ 17,043 Cash 2021: € 17,043 First fiscal year in the series	€ 19,448 Cash 2022: € 19,448 ▲ 14% vs 2021 (€ 17,043) Favourable step	€ 1,412 Cash 2023: € 1,412 ▼ 93% vs 2022 (€ 19,448) Unfavourable step	€ 30,614 Cash 2024: € 30,614 ▲ € 29,202 vs 2023 (€ 1,412) Favourable step	▲ € 29,202
Land & buildings	€ 31,129 Land & buildings 2021: € 31,129 First fiscal year in the series	€ 28,873 Land & buildings 2022: € 28,873 ▼ 7% vs 2021 (€ 31,129) Unchanged	€ 32,699 Land & buildings 2023: € 32,699 ▲ 13% vs 2022 (€ 28,873) Unchanged	€ 23,340 Land & buildings 2024: € 23,340 ▼ 29% vs 2023 (€ 32,699) Unchanged	▼ 29%
Retained profit	€ 76,872 Retained profit 2021: € 76,872 First fiscal year in the series	€ 54,477 Retained profit 2022: € 54,477 ▼ 29% vs 2021 (€ 76,872) Unfavourable step	€ 43,813 Retained profit 2023: € 43,813 ▼ 20% vs 2022 (€ 54,477) Unfavourable step	€ 37,508 Retained profit 2024: € 37,508 ▼ 14% vs 2023 (€ 43,813) Unfavourable step	▼ 14%
Dividend	€ 5,000 Dividend 2021: € 5,000 First fiscal year in the series	€ 11,000 Dividend 2022: € 11,000 ▲ 120% vs 2021 (€ 5,000) Unchanged	€ 10,190 Dividend 2023: € 10,190 ▼ 7% vs 2022 (€ 11,000) Unchanged	€ 21,570 Dividend 2024: € 21,570 ▲ 112% vs 2023 (€ 10,190) Unchanged	▲ 112%
Bank debt	€ 33,085 Bank debt 2021: € 33,085 First fiscal year in the series	€ 23,308 Bank debt 2022: € 23,308 ▼ 30% vs 2021 (€ 33,085) Favourable step	€ 13,446 Bank debt 2023: € 13,446 ▼ 42% vs 2022 (€ 23,308) Favourable step	€ 6,372 Bank debt 2024: € 6,372 ▼ 53% vs 2023 (€ 13,446) Favourable step	▼ 53%
Balance sheet total	€ 238,589 Balance sheet total 2021: € 238,589 First fiscal year in the series	€ 203,733 Balance sheet total 2022: € 203,733 ▼ 15% vs 2021 (€ 238,589) Unchanged	€ 179,112 Balance sheet total 2023: € 179,112 ▼ 12% vs 2022 (€ 203,733) Unchanged	€ 177,846 Balance sheet total 2024: € 177,846 ▼ 1% vs 2023 (€ 179,112) Unchanged	▼ 1%

Key figures of Pharmacie WAGMANS-CREMA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Pharmacie WAGMANS-CREMA?

What happened at Pharmacie WAGMANS-CREMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2025 New annual accounts for financial year 2024: profit of € 15,265. filed late Source: NBB ↗
Feb 23, 2009 New establishment in Dalhem. KBO
Feb 17, 2009 Start of the company according to the CBE. KBO

In short

From € 42,761 loss in 2021 to € 15,265 profit in 2024.

Paid € 4,375 in corporate taxes since 2021.

Best year ever: 2024, with € 15,265 profit.

Paid out € 47,760 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Daniella CREMA

Pharmacie WAGMANS-CREMA

Behind Pharmacie WAGMANS-CREMA is Daniella CREMA.

Directors

According to the 2024 annual accounts

Daniella CREMA

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Fusillés(BER) 5

4607 Dalhem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0809.878.140
VAT number: BE 0809.878.140
Registered office: Rue des Fusillés(BER) 5, 4607 Dalhem
Names & denominations: Pharmacie WAGMANS-CREMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 February 2009
Peppol: Active · Active since 27 Dec 2024
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗